How to actually relieve menopause symptoms — what the evidence says

What we checked — and why we landed where mainstream guidance now agrees

The field of menopause medicine has undergone a significant evidence correction since the early 2000s, when a flawed reading of the Women's Health Initiative trial caused a generation of clinicians to stop prescribing — and a generation of women to stop asking for — the treatment most likely to help them. We reviewed the original WHI data and its subsequent reanalyses, the current position statements from the major international menopause societies, randomised trial evidence on non-hormonal alternatives, and the independent NICE guideline on menopause, to give you a picture that reflects the science as it actually stands in 2026.

• ✓
  WHI study and subsequent reanalyses reviewed The original 2002 WHI findings that alarmed clinicians have since been substantially reinterpreted: the elevated risks applied primarily to older women starting hormones a decade or more after menopause, not to the typical candidate for MHT.
• ✓
  International Menopause Society & The Menopause Society position statements cross-checked Both bodies now state clearly that MHT is appropriate first-line therapy for menopausal symptoms in healthy women under 60 or within 10 years of their last period, and that the risk-benefit balance is favourable for the majority.
• ✓
  NICE guideline NG23 (updated 2024) reviewed The UK's National Institute for Health and Care Excellence recommends MHT for bothersome menopausal symptoms and states that for most women it does not meaningfully increase breast cancer risk when used for the recommended duration.
• ✓
  Non-hormonal alternatives assessed against randomised trial evidence Fezolinetant (a neurokinin B antagonist), venlafaxine, and CBT all have randomised controlled trial evidence supporting their use in women who cannot or choose not to use MHT; herbal products and most supplements do not.

There is no single answer — but there is a clear hierarchy of evidence

The right approach depends on your symptoms, your medical history, and how much disruption you're willing to tolerate while waiting for things to work — here's how to think through the choices.

What women try first that the evidence doesn't support

The supplement and wellness industry has moved aggressively into the menopause space, and several popular products are either backed by weak evidence, carry real risks, or simply delay women from accessing treatments that actually work.

• ✗
  Black cohosh and most herbal supplements — Cochrane reviews and systematic analyses consistently find that black cohosh, red clover isoflavones, and similar supplements do not meaningfully outperform placebo for hot flushes; some herbal products also carry documented risks of liver toxicity, and none are regulated to pharmaceutical standards of purity or dosing.
• ✗
  "Bioidentical" compounded hormone creams from compounding pharmacies — Custom-compounded "bioidentical" preparations are not the same thing as regulated body-identical hormones (like micronised progesterone); they are unregulated, unstandardised in dose, and have no safety or efficacy data — meaning you are taking an unknown dose of hormones with no clinical oversight and no quality assurance.
• ✗
  Refusing all treatment because of the 2002 HRT scare — The Women's Health Initiative findings have been substantially reanalysed and the original alarming headlines have not held up — continuing to avoid evidence-based treatment because of a 24-year-old misreported study means accepting years of unnecessary suffering on the basis of outdated science.
• ✗
  Relying only on lifestyle changes for severe vasomotor symptoms — Cooling the bedroom, reducing alcohol, and avoiding spicy food can modestly reduce hot flush triggers, but for women with frequent, severe hot flushes and night sweats, lifestyle modification alone rarely produces clinically meaningful relief — it works best as an adjunct to medical treatment, not a replacement for it.